Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator

Abstract Although trypsin-like serine proteases have flexible surface-exposed loops and are known to adopt higher and lower activity conformations, structural determinants for the different conformations have remained largely obscure. The trypsin-like serine protease, urokinase-type plasminogen acti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tobias Kromann-Hansen, Eva Louise Lange, Hans Peter Sørensen, Gholamreza Hassanzadeh-Ghassabeh, Mingdong Huang, Jan K. Jensen, Serge Muyldermans, Paul J. Declerck, Elizabeth A. Komives, Peter A. Andreasen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/409897e4334a4c2c81d516f9a73f9d64
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:409897e4334a4c2c81d516f9a73f9d64
record_format dspace
spelling oai:doaj.org-article:409897e4334a4c2c81d516f9a73f9d642021-12-02T11:40:33ZDiscovery of a novel conformational equilibrium in urokinase-type plasminogen activator10.1038/s41598-017-03457-72045-2322https://doaj.org/article/409897e4334a4c2c81d516f9a73f9d642017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03457-7https://doaj.org/toc/2045-2322Abstract Although trypsin-like serine proteases have flexible surface-exposed loops and are known to adopt higher and lower activity conformations, structural determinants for the different conformations have remained largely obscure. The trypsin-like serine protease, urokinase-type plasminogen activator (uPA), is central in tissue remodeling processes and also strongly implicated in tumor metastasis. We solved five X-ray crystal structures of murine uPA (muPA) in the absence and presence of allosteric molecules and/or substrate-like molecules. The structure of unbound muPA revealed an unsuspected non-chymotrypsin-like protease conformation in which two β-strands in the core of the protease domain undergoes a major antiparallel-to-parallel conformational transition. We next isolated two anti-muPA nanobodies; an active-site binding nanobody and an allosteric nanobody. Crystal structures of the muPA:nanobody complexes and hydrogen-deuterium exchange mass spectrometry revealed molecular insights about molecular factors controlling the antiparallel-to-parallel equilibrium in muPA. Together with muPA activity assays, the data provide valuable insights into regulatory mechanisms and conformational flexibility of uPA and trypsin-like serine proteases in general.Tobias Kromann-HansenEva Louise LangeHans Peter SørensenGholamreza Hassanzadeh-GhassabehMingdong HuangJan K. JensenSerge MuyldermansPaul J. DeclerckElizabeth A. KomivesPeter A. AndreasenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tobias Kromann-Hansen
Eva Louise Lange
Hans Peter Sørensen
Gholamreza Hassanzadeh-Ghassabeh
Mingdong Huang
Jan K. Jensen
Serge Muyldermans
Paul J. Declerck
Elizabeth A. Komives
Peter A. Andreasen
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
description Abstract Although trypsin-like serine proteases have flexible surface-exposed loops and are known to adopt higher and lower activity conformations, structural determinants for the different conformations have remained largely obscure. The trypsin-like serine protease, urokinase-type plasminogen activator (uPA), is central in tissue remodeling processes and also strongly implicated in tumor metastasis. We solved five X-ray crystal structures of murine uPA (muPA) in the absence and presence of allosteric molecules and/or substrate-like molecules. The structure of unbound muPA revealed an unsuspected non-chymotrypsin-like protease conformation in which two β-strands in the core of the protease domain undergoes a major antiparallel-to-parallel conformational transition. We next isolated two anti-muPA nanobodies; an active-site binding nanobody and an allosteric nanobody. Crystal structures of the muPA:nanobody complexes and hydrogen-deuterium exchange mass spectrometry revealed molecular insights about molecular factors controlling the antiparallel-to-parallel equilibrium in muPA. Together with muPA activity assays, the data provide valuable insights into regulatory mechanisms and conformational flexibility of uPA and trypsin-like serine proteases in general.
format article
author Tobias Kromann-Hansen
Eva Louise Lange
Hans Peter Sørensen
Gholamreza Hassanzadeh-Ghassabeh
Mingdong Huang
Jan K. Jensen
Serge Muyldermans
Paul J. Declerck
Elizabeth A. Komives
Peter A. Andreasen
author_facet Tobias Kromann-Hansen
Eva Louise Lange
Hans Peter Sørensen
Gholamreza Hassanzadeh-Ghassabeh
Mingdong Huang
Jan K. Jensen
Serge Muyldermans
Paul J. Declerck
Elizabeth A. Komives
Peter A. Andreasen
author_sort Tobias Kromann-Hansen
title Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
title_short Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
title_full Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
title_fullStr Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
title_full_unstemmed Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
title_sort discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/409897e4334a4c2c81d516f9a73f9d64
work_keys_str_mv AT tobiaskromannhansen discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
AT evalouiselange discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
AT hanspetersørensen discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
AT gholamrezahassanzadehghassabeh discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
AT mingdonghuang discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
AT jankjensen discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
AT sergemuyldermans discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
AT pauljdeclerck discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
AT elizabethakomives discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
AT peteraandreasen discoveryofanovelconformationalequilibriuminurokinasetypeplasminogenactivator
_version_ 1718395576876269568